微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.6% | -1.84% | -77.84% | 54/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.22% | -1.77% | 16.45% | 40/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.2% | -2.82% | 105.98% | 42/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.01% | -35.96% | 84.66% | 56/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.63% | -40.07% | -77.82% | 53/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 7.35% | 18.36% | 15.2% | 47/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 6.38% | 38.1% | 35.74% | 47/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.7% | 57.72% | 72.79% | 43/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.72% | 223.81% | -56.2% | 36/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 6.21% | -1.27% | 34.42% | 64/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.62% | 18.77% | 55.03% | 67/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.98% | 38.6% | 254.76% | 68/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.84% | 47.37% | -86.65% | 90/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 6.29% | -1.87% | 61.7% | 88/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.89% | -7.6% | 80.93% | 92/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.15% | -22.94% | 277.19% | 94/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.57% | -38.04% | -91.11% | 95/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.41% | 26.93% | 52.26% | 103/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 4.21% | 81.47% | 50.9% | 94/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.79% | 93.75% | 203.26% | 102/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 0.92% | 15% | -81.78% | 90/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 5.05% | 113.98% | 117.67% | 107/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 2.32% | 29.61% | 61.11% | 77/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 1.44% | -26.9% | 80% | 97/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.8% | 60% | -66.1% | 61/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 2.36% | -10.61% | 31.84% | 102/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 1.79% | -53.51% | -9.14% | 60/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.97% | -40.84% | 294% | 62/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.5% | -25.37% | -81.06% | 50/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.64% | -46.34% | -31.43% | 91/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 3.85% | 15.96% | 15.62% | 46/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.33% | 20.22% | 397.01% | 39/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.67% | 15.52% | -86.38% | 46/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 4.92% | -42.59% | 48.19% | 82/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.32% | -15.09% | 19.86% | 44/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.77% | -12.06% | 377.59% | 45/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.58% | -3.33% | -93.23% | 41/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.57% | 0.35% | 119.18% | 57/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 3.91% | -16.81% | 24.13% | 33/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 3.15% | -18.6% | 425% | 37/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 0.6% | -36.17% | -92.97% | 29/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |